Virginia Retirement Systems’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-189,800
| Closed | -$854K | – | 1343 |
|
|
2026
Q1 | $854K | Buy |
+189,800
| New | +$989K | 0.01% | 636 |
|
|
2022
Q4 | – | Sell |
-11,400
| Closed | -$218K | – | 1197 |
|
|
2022
Q3 | $218K | Buy |
+11,400
| New | +$262K | ﹤0.01% | 1035 |
|
|
2020
Q3 | – | Sell |
-36,300
| Closed | -$412K | – | 1143 |
|
|
2020
Q2 | $412K | Sell |
36,300
-8,200
| -18% | -$116K | ﹤0.01% | 869 |
|
|
2020
Q1 | $637K | Sell |
44,500
-1,900
| -4% | -$40.1K | 0.01% | 711 |
|
|
2019
Q4 | $1.26M | Sell |
46,400
-1,400
| -3% | -$38.5K | 0.01% | 595 |
|
|
2019
Q3 | $1.37M | Buy |
47,800
+4,900
| +11% | +$143K | 0.02% | 565 |
|
|
2019
Q2 | $1.19M | Buy |
42,900
+2,100
| +5% | +$59.3K | 0.01% | 611 |
|
|
2019
Q1 | $1.35M | Buy |
40,800
+1,100
| +3% | +$33.5K | 0.02% | 557 |
|
|
2018
Q4 | $1.15M | Buy |
39,700
+13,400
| +51% | +$482K | 0.02% | 570 |
|
|
2018
Q3 | $1.21M | Sell |
26,300
-2,300
| -8% | -$102K | 0.01% | 640 |
|
|
2018
Q2 | $1.07M | Buy |
+28,600
| New | +$966K | 0.01% | 662 |
|
|
2018
Q1 | – | Sell |
-43,600
| Closed | -$1.5M | – | 1033 |
|
|
2017
Q4 | $1.5M | Sell |
43,600
-4,900
| -10% | -$165K | 0.02% | 553 |
|
|
2017
Q3 | $1.75M | Sell |
48,500
-12,300
| -20% | -$351K | 0.02% | 537 |
|
|
2017
Q2 | $1.57M | Buy |
60,800
+12,000
| +25% | +$255K | 0.02% | 528 |
|
|
2017
Q1 | $937K | Buy |
+48,800
| New | +$865K | 0.01% | 672 |
|
|
2015
Q4 | $229K | Sell |
5,300
-2,900
| -35% | -$123K | ﹤0.01% | 931 |
|
|
2015
Q3 | $307K | Hold |
8,200
| – | – | ﹤0.01% | 823 |
|
|
2015
Q2 | $279K | Hold |
8,200
| – | – | ﹤0.01% | 861 |
|
|
2015
Q1 | $290K | Hold |
8,200
| – | – | ﹤0.01% | 844 |
|
|
2014
Q4 | $279K | Hold |
8,200
| – | – | ﹤0.01% | 835 |
|
|
2014
Q3 | $316K | Hold |
8,200
| – | – | 0.01% | 795 |
|
|
2014
Q2 | $319K | Sell |
8,200
-600
| -7% | -$22.3K | 0.01% | 800 |
|
|
2014
Q1 | $301K | Sell |
8,800
-21,200
| -71% | -$657K | 0.01% | 788 |
|
|
2013
Q4 | $629K | Sell |
30,000
-11,400
| -28% | -$288K | 0.01% | 576 |
|
|
2013
Q3 | $973K | Buy |
41,400
+4,700
| +13% | +$134K | 0.02% | 470 |
|
|
2013
Q2 | $986K | Buy |
+36,700
| New | +$1.06M | 0.02% | 449 |
|
Other funds holding MYGN
VPC
Virginia Retirement Systems's MYGN Position: Q2 2026 in Review
Virginia Retirement Systems sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 189,800 shares — an estimated $854K sold.
Virginia Retirement Systems first reported a position in MYGN in Q2 2013 and held it in 26 quarters. The position peaked at $1.75M in Q3 2017. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Virginia Retirement Systems reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
- Virginia Retirement Systems sold 189,800 Myriad Genetics shares in Q2 2026, an estimated $854K.
- Virginia Retirement Systems first reported a position in Myriad Genetics in Q2 2013 and held it in 26 quarters.
- Virginia Retirement Systems's Myriad Genetics position peaked at $1.75M in Q3 2017.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.